Recent Insider Activity Could Benefit Akero Therapeutics Inc (AKRO)
Akero Therapeutics Inc’s filing revealed that its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.35 million on
Akero Therapeutics Inc’s filing revealed that its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.35 million on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Akero Therapeutics Inc revealed its Chief Development Officer Yale Catriona unloaded Company’s shares for reported $0.51 million
In a filing, Akero Therapeutics Inc revealed its President and CEO Cheng Andrew unloaded Company’s shares for reported $2.0 million
Akero Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.28 million
Akero Therapeutics Inc’s recent filing unveils that its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.28 million
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Akero Therapeutics
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.